靶向人SET8单抗的制备及对肝癌细胞增殖、凋亡及细胞周期的影响
作者:
作者单位:

河北医科大学第四医院

基金项目:

河北省重点研发计划项目(21377759D)


Preparation of human SET8 monoclonal antibody and its effect on hepatocellular carcinoma cell proliferation, apoptosis and cell cycle
Author:
Affiliation:

The Fourth Hospital of Hebei Medical University

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    目的 制备针对人SET8的单克隆抗体,并探索其对肝癌细胞增殖、凋亡及细胞周期的影响,同时评估其在肝癌小鼠模型中的抗肿瘤效果。方法 通过人SET8多肽片段免疫小鼠,筛选并融合B细胞与骨髓瘤细胞,建立稳定分泌SET8单抗的杂交瘤细胞株。通过小鼠腹腔注射、腹水采集的方式生产并纯化。采用CCK-8法、流式细胞术及Western blot技术,分别分析SET8单抗对肝癌细胞增殖、凋亡、细胞周期及凋亡相关蛋白表达的影响。最后,构建人肝癌细胞移植瘤小鼠模型,体内评估SET8单抗对肿瘤生长的抑制作用。结果 人SET8单抗在50ug/ml和100ug/ml浓度下显著抑制Huh-7和Mahlavu肝癌细胞活力,且浓度越高抑制效果越强。流式细胞术分析显示,相较于对照组,SET8单抗、紫杉醇及二者联合处理均显著提高Mahlavu细胞凋亡率,且联合组效果最佳。同时,SET8单抗诱导Mahlavu细胞周期阻滞于S和G2期,减少G1期细胞。Western blot分析显示,该单抗增加凋亡相关蛋白Bax和caspase-3的表达。体内实验显示,SET8单抗单独或联合紫杉醇均有效抑制肝癌细胞在裸鼠体内的增殖,联合治疗效果最为显著。结论 制备的人SET8单抗有效抑制肝癌细胞增殖、促进肝癌细胞凋亡,并在动物体内展现出良好的抗肿瘤效果。

    Abstract:

    Objective To prepare human SET8 monoclonal antibody and explore its effects on the proliferation, apoptosis and cell cycle of hepatoma cells, and evaluate its anti-tumor effect in mouse models of hepatocellular carcinoma. Methods By immunizing mice with human SET8 polypeptide fragment, B cells and myeloma cells were screened and fused to establish hybridoma cell line that secreted SET8 monoclonal antibody stably. The production was expanded by intraperitoneal injection of mice and collection and purification of ascites. The CCK-8, flow cytometry and Western blot were used to analyze the effects of SET8 monoclonal antibody on the proliferation, apoptosis, cell cycle and apoptosis-related protein expression of hepatocellular carcinoma cells. Finally, a mouse model of human hepatocellular carcinoma cell transplantation was constructed to evaluate the inhibitory effect of SET8 monoclonal antibody on tumor growth in vivo. Results Human SET8 monoclonal antibody significantly inhibited the viability of Huh-7 and Mahlavu hepatoma cells at the concentration of 50ug/ml and 100ug/ml, and the higher the concentration, the stronger the inhibitory effect. Flow cytometry analysis showed that compared with the control group, SET8 monoclonal antibody, paclitaxel and their combination treatment significantly increased the apoptosis rate of Mahlavu cells, and the combination group had the best effect. Meanwhile, SET8 monoclonal antibody induced Mahlavu cell cycle arrest in S and G2 phases and reduced G1 phase cells. Western blot analysis showed that the monoclonal antibody increased the expression of apoptosis-related proteins Bax and caspase-3. Further animal experiments showed that SET8 monoclonal antibody alone or in combination with paclitaxel effectively inhibited the proliferation of hepatocellular carcinoma cells in nude mice, and the combination therapy had the most significant effect. Conclusion The prepared human SET8 monoclonal antibody effectively inhibited the proliferation of hepatocellular carcinoma cells, promoted the apoptosis of hepatocellular carcinoma cells, and showed a good anti-tumor effect in animals.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-08-22
  • 最后修改日期:2024-10-09
  • 录用日期:2025-01-15
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭